Clinical implications of KRAS mutations in lung cancer patients treated with tyrosine kinase inhibitors: an important role for mutations in minor clones (Q27851527)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Clinical implications of KRAS mutations in lung cancer patients treated with tyrosine kinase inhibitors: an important role for mutations in minor clones
scientific article

    Statements

    Clinical implications of KRAS mutations in lung cancer patients treated with tyrosine kinase inhibitors: an important role for mutations in minor clones (English)
    1 reference
    Antonio Marchetti
    0 references
    Michele Milella
    0 references
    Lara Felicioni
    0 references
    Federico Cappuzzo
    0 references
    Luciana Irtelli
    0 references
    Maela Del Grammastro
    0 references
    Mariagrazia Sciarrotta
    0 references
    Sara Malatesta
    0 references
    Carmen Nuzzo
    0 references
    Giovanna Finocchiaro
    0 references
    Bruno Perrucci
    0 references
    Donatella Carlone
    0 references
    Alain J Gelibter
    0 references
    Anna Ceribelli
    0 references
    Andrea Mezzetti
    0 references
    Stefano Iacobelli
    0 references
    Francesco Cognetti
    0 references
    Fiamma Buttitta
    0 references
    October 2009
    0 references
    0 references
    11
    0 references
    10
    0 references
    1084-92
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit